Targeting estrogen receptor improves progression-free survival in advanced breast can

[News]

Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease...

More... (http://www.medicalnewstoday.com/releases/313382.php)